FindTrial
Sign In

Survival after exenteration surgery for rectal cancer

Outcomes of Pelvic Exenteration in Rectal cancer: An Institutional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045958
Enrollment
80
Registered
2022-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C20- Malignant neoplasm of rectum

Interventions

None listed

Sponsors

Malabar Cancer Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with rectal cancer who underwent pelvic exenteration in Malabar Cancer Center during the period Jan 2009- Dec 2020

Exclusion criteria

Exclusion criteria: Second malignancy except non-melanomatous skin cancers

Design outcomes

Primary

MeasureTime frame
Overall survival Disease free survival Recurrence rates will be assessed Timepoint: overall survival and disease-free survival at 3 yrs and 5 yrs—

Secondary

MeasureTime frame
morbidity and mortality ratesTimepoint: 30 day morbidity and 30 day mortality—

Countries

India

Contacts

Public ContactVijayasarathy

Malabar Cancer Centre, Thalassery

drvijiayasarathy1988@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026